2024 Q2 Form 10-Q Financial Statement

#000157551524000095 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.894B $1.884B
YoY Change 9.24% 19.49%
Cost Of Revenue $1.175B $1.161B
YoY Change 8.48% 15.72%
Gross Profit $718.4M $722.3M
YoY Change 10.51% 26.1%
Gross Profit Margin 37.94% 38.34%
Selling, General & Admin $556.4M $539.8M
YoY Change 14.43% 14.17%
% of Gross Profit 77.45% 74.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.23M $34.52M
YoY Change -4.81% 11.33%
% of Gross Profit 4.63% 4.78%
Operating Expenses $556.4M $539.8M
YoY Change 14.43% 7.32%
Operating Profit $127.3M $148.3M
YoY Change 25.41% 112.23%
Interest Expense $139.0K -$818.0K
YoY Change -106.26% -41.53%
% of Operating Profit 0.11% -0.55%
Other Income/Expense, Net
YoY Change
Pretax Income $127.5M $147.4M
YoY Change 28.35% 143.83%
Income Tax $32.17M $33.35M
% Of Pretax Income 25.24% 22.62%
Net Earnings $95.29M $114.1M
YoY Change 25.12% 152.88%
Net Earnings / Revenue 5.03% 6.06%
Basic Earnings Per Share $0.95 $1.13
Diluted Earnings Per Share $0.94 $1.12
COMMON SHARES
Basic Shares Outstanding 100.5M shares 101.2M
Diluted Shares Outstanding 101.2M shares 102.0M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $177.3M $312.3M
YoY Change -39.87% 6.49%
Cash & Equivalents $177.3M $312.3M
Short-Term Investments
Other Short-Term Assets $33.77M $32.71M
YoY Change -19.01% 4148.05%
Inventory $325.6M $316.2M
Prepaid Expenses
Receivables $31.38M $36.31M
Other Receivables $0.00 $0.00
Total Short-Term Assets $568.1M $697.5M
YoY Change -13.4% 3.52%
LONG-TERM ASSETS
Property, Plant & Equipment $836.0M $809.5M
YoY Change 16.87% 12.08%
Goodwill $381.8M $381.8M
YoY Change 0.01% 3.5%
Intangibles $208.1M $208.1M
YoY Change 0.0% 12.49%
Long-Term Investments
YoY Change
Other Assets $14.49M $12.29M
YoY Change 10.54% -12.22%
Total Long-Term Assets $2.842B $2.775B
YoY Change 13.09% 15.79%
TOTAL ASSETS
Total Short-Term Assets $568.1M $697.5M
Total Long-Term Assets $2.842B $2.775B
Total Assets $3.411B $3.472B
YoY Change 7.61% 13.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $158.8M $201.4M
YoY Change -15.52% 16.5%
Accrued Expenses $193.8M $190.2M
YoY Change 30.19% 25.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.119M $1.089M
YoY Change 14.65% 7.61%
Total Short-Term Liabilities $549.8M $585.9M
YoY Change 6.72% 12.17%
LONG-TERM LIABILITIES
Long-Term Debt $8.057M $133.4M
YoY Change -96.55% -48.48%
Other Long-Term Liabilities $38.66M $37.56M
YoY Change 6.15% 3.35%
Total Long-Term Liabilities $38.66M $37.56M
YoY Change 6.15% 3.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $549.8M $585.9M
Total Long-Term Liabilities $38.66M $37.56M
Total Liabilities $2.141B $2.261B
YoY Change 1.08% 11.73%
SHAREHOLDERS EQUITY
Retained Earnings $477.8M $427.3M
YoY Change 60.88% 33.54%
Common Stock $791.5M $783.7M
YoY Change 4.98% 7.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.269B $1.211B
YoY Change
Total Liabilities & Shareholders Equity $3.411B $3.472B
YoY Change 7.61% 13.09%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $95.29M $114.1M
YoY Change 25.12% 152.88%
Depreciation, Depletion And Amortization $33.23M $34.52M
YoY Change -4.81% 11.33%
Cash From Operating Activities $91.60M $219.7M
YoY Change -49.06% 240.41%
INVESTING ACTIVITIES
Capital Expenditures $57.68M $51.24M
YoY Change 22.62% 18.45%
Acquisitions $0.00
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$57.68M -$51.24M
YoY Change -4.0% 18.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -168.8M -$57.97M
YoY Change 42.95% 31.34%
NET CHANGE
Cash From Operating Activities 91.60M $219.7M
Cash From Investing Activities -57.68M -$51.24M
Cash From Financing Activities -168.8M -$57.97M
Net Change In Cash -134.9M $110.5M
YoY Change -8254.72% -583.31%
FREE CASH FLOW
Cash From Operating Activities $91.60M $219.7M
Capital Expenditures $57.68M $51.24M
Free Cash Flow $33.92M $168.5M
YoY Change -74.46% 691.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101211984 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101211984 shares
CY2024Q1 us-gaap Gross Profit
GrossProfit
722313000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
650062000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
539771000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
486195000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32232000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34068000 usd
CY2024Q1 sfm Income Expense Store Closure And Other Costs Net
IncomeExpenseStoreClosureAndOtherCostsNet
2044000 usd
CY2023Q2 sfm Income Expense Store Closure And Other Costs Net
IncomeExpenseStoreClosureAndOtherCostsNet
28277000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
148266000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
101522000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-818000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2220000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
147448000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
99302000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33348000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23142000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
114100000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
76160000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101071000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103827000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102024000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104876000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1148547000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
114100000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2283000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
60380000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6477000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1211027000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1046462000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
76160000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5488000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
99171000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3852000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
18139000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1050930000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
114100000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
76160000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34522000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34912000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32303000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
30696000 usd
CY2024Q1 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
27845000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6477000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3852000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1072000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-386000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-496000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8601000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6241000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6996000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5400000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14691000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9528000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-924000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2609000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28899000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
27006000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17642000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2024000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-17667000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-13712000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
8869000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
5456000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-36580000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-33956000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1650000 usd
CY2023Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
179000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
219695000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
179820000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51241000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47044000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13042000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51241000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60086000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2023Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
25000000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
253000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
219000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
60000000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
98349000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2283000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5488000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57970000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-118080000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
110484000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1654000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
203870000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
295192000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
314354000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
296846000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
2411000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
3641000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
151000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
54000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
23599000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20924000 usd
CY2024Q1 sfm Excise Tax Accrued On Repurchase Of Common Stock
ExciseTaxAccruedOnRepurchaseOfCommonStock
2146000 usd
CY2023Q2 sfm Excise Tax Accrued On Repurchase Of Common Stock
ExciseTaxAccruedOnRepurchaseOfCommonStock
822000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
72791000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
138662000 usd
CY2024Q1 us-gaap Number Of Stores
NumberOfStores
414 store
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
23 state
CY2024Q1 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its results of operations on a 52- or 53-week fiscal calendar ending on the Sunday closest to December 31. The fiscal year ending December 29, 2024 (“fiscal year 2024”) and fiscal year 2023 are 52-week years. The Company reports its results of operations on a 13-week quarter, except for 53-week fiscal years (in which the fourth quarter has 14 weeks).</span></div>
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10566000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10906000 usd
CY2024Q1 sfm Contract With Customer Liability Liabilities Incurred
ContractWithCustomerLiabilityLiabilitiesIncurred
1166000 usd
CY2023Q2 sfm Contract With Customer Liability Liabilities Incurred
ContractWithCustomerLiabilityLiabilitiesIncurred
1222000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2532000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2582000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
9200000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
9546000 usd
CY2024Q1 sfm Stock Repurchase Program Average Cost Per Share Acquired
StockRepurchaseProgramAverageCostPerShareAcquired
63.04
CY2023Q2 sfm Stock Repurchase Program Average Cost Per Share Acquired
StockRepurchaseProgramAverageCostPerShareAcquired
32.64
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
60380000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
99171000 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
8375000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
8685000 usd
CY2024Q1 sfm Long Term Debt And Finance Lease Liabilities Noncurrent
LongTermDebtAndFinanceLeaseLiabilitiesNoncurrent
133375000 usd
CY2023Q4 sfm Long Term Debt And Finance Lease Liabilities Noncurrent
LongTermDebtAndFinanceLeaseLiabilitiesNoncurrent
133685000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.226
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2024Q1 sfm Employee Service Share Based Compensation Tax Benefit Detriment From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitDetrimentFromExerciseOfStockOptions
4500000 usd
CY2023Q2 sfm Employee Service Share Based Compensation Tax Benefit Detriment From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitDetrimentFromExerciseOfStockOptions
2600000 usd
CY2024Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
957780 shares
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3038411 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
114100000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
76160000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101071000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103827000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
114100000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
76160000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101071000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103827000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
404000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
395000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102024000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104876000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1883808000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1733310000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
27800000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6477000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3852000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
567000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
740000 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
338000 shares
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
481000 shares
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
47609000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
381800000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
381700000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2023 sfm Number Of Store Closures
NumberOfStoreClosures
11 store
CY2023Q1 sfm Store Performance Capacity Rate
StorePerformanceCapacityRate
0.30
CY2023 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
5900000 usd
CY2023Q2 sfm Restructuring And Related Cost Accelerated Depreciation Incurred Cost
RestructuringAndRelatedCostAcceleratedDepreciationIncurredCost
4000000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001575515-24-000095-index-headers.html Edgar Link pending
0001575515-24-000095-index.html Edgar Link pending
0001575515-24-000095.txt Edgar Link pending
0001575515-24-000095-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfm-20240331.htm Edgar Link pending
sfm-20240331.xsd Edgar Link pending
sfm-20240331xex101.htm Edgar Link pending
sfm-20240331xex311.htm Edgar Link pending
sfm-20240331xex312.htm Edgar Link pending
sfm-20240331xex321.htm Edgar Link pending
sfm-20240331xex322.htm Edgar Link pending
sfm-20240331_g1.jpg Edgar Link pending
Show.js Edgar Link pending
sfm-20240331_lab.xml Edgar Link unprocessable
sfm-20240331_pre.xml Edgar Link unprocessable
sfm-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
sfm-20240331_def.xml Edgar Link unprocessable
sfm-20240331_cal.xml Edgar Link unprocessable